Literature DB >> 9220353

Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions.

F C Brosius1, Y Liu, N Nguyen, D Sun, J Bartlett, M Schwaiger.   

Abstract

Persistently ischemic myocardium exhibits increased glucose uptake which may contribute to the preservation of myocardial function and viability. Little is known about the specific molecular events which are responsible for this increase in uptake. Therefore, we investigated whether myocardial ischemia induces the gene expression of the major cardiac facilitative glucose transporters, GLUT4 and GLUT1. We determined the expression of myocardial glucose transporter mRNAs and polypeptides after 6 h of regional ischemia in a dog model by semi-quantitative Northern blotting and immunoblotting. GLUT1 but not GLUT4 expression was significantly increased in both ischemic and non-ischemic regions from the experimental hearts when compared to surgical control and normal hearts. GLUT1 mRNA expression was increased 3.4-fold and GLUT1 polypeptide expression was increased 1.7-fold in ischemic hearts when compared to normal or surgical-control hearts. There were no significant regional differences in GLUT1 expression in either normal or ischemic hearts. However, there was a tendency for GLUT1 mRNA expression to be highest in the non-ischemic regions from the 6-h ischemia hearts. These findings suggest that myocardial ischemia induces a factor or factors which stimulate GLUT1 expression in non-ischemic as well as ischemic myocardial regions. Increased GLUT1 expression may play a role in augmenting glucose uptake during ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220353     DOI: 10.1006/jmcc.1997.0405

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  24 in total

1.  Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply.

Authors:  M C Sugden; M L Langdown; R A Harris; M J Holness
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 2.  Cellular and molecular regulation of cardiac glucose transport.

Authors:  L H Young; D L Coven; R R Russell
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

3.  Is having a sweetheart enough to survive?

Authors:  Samia Massalha; Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2018-09-06       Impact factor: 5.952

Review 4.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

5.  Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.

Authors:  Koichi Morita; Chietsugu Katoh; Keiichiro Yoshinaga; Kazuyuki Noriyasu; Megumi Mabuchi; Takahiro Tsukamoto; Hiroyuki Kageyama; Tohru Shiga; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-18       Impact factor: 9.236

6.  FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.

Authors:  Lisa Gross; Lisa Paintmayer; Sebastian Lehner; Lydia Brandl; Christoph Brenner; Ulrich Grabmaier; Bruno Huber; Peter Bartenstein; Hans-Diogenes Theiss; Wolfgang-Michael Franz; Steffen Massberg; Andrei Todica; Stefan Brunner
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-09-28       Impact factor: 6.875

7.  Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.

Authors:  Maximilian Wiesmann; Monica Roelofs; Robert van der Lugt; Arend Heerschap; Amanda J Kiliaan; Jurgen Ahr Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

8.  Abnormal expression of the peptide transporter PepT1 in the colon of massive bowel resection rat: a potential route for colonic mucosa damage by transport of fMLP.

Authors:  Bin Shi; Desheng Song; Hua Xue; Jinhai Li; Ning Li; Jieshou Li
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

9.  Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy.

Authors:  Charles W Heilig; Thomas Saunders; Frank C Brosius; Kelle Moley; Kathleen Heilig; Raymond Baggs; LiRong Guo; David Conner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

10.  Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.

Authors:  Xiaoli Zhang; Thomas H Schindler; John O Prior; James Sayre; Magnus Dahlbom; Sung-Cheng Huang; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.